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Abstract
Acute pancreatitis is a common diagnosis worldwide, with gallstone disease being the most
prevalent cause (50%). The American College of Gastroenterology recommends urgent
endoscopic retrograde cholangiopancreatography (ERCP) (within 24 h) for patients with bili-
ary pancreatitis accompanied by cholangitis. Most international guidelines recommend that
ERCP be performed within 72 h in patients with biliary pancreatitis and a bile duct obstruction
without cholangitis, but the optimal timing for endoscopy is controversial. We investigated the
optimal timing for ERCP in patients with biliary pancreatitis and a bile duct obstruction without
cholangitis, and whether performing endoscopy within 24 h is superior to performing it after
24 h. We analyzed the clinical data of 505 patients with newly diagnosed acute pancreatitis,
from January 1, 2005 to December 31, 2014. We divided the patients into two groups accord-
ing to the timing of ERCP: < 24 h (urgent) and 24–72 h (early).Among the 505 patients, 73
were diagnosed with biliary pancreatitis and a bile duct obstruction without cholangitis. The
mean age of the patients was 55 years (range: 26–90 years). Bile duct stones and biliary
sludge were identified on endoscopy in 45 (61.6%) and 11 (15.0%) patients, respectively.
The timing of ERCP within 72 h was not associated with ERCP-related complications (P =
0.113), and the total length of hospital stay was not different between urgent and early ERCP
(5.9 vs. 5.7 days, P = 0.174). No significant differences were found in total length of hospitali-
zation or procedural-related complications, in patients with biliary pancreatitis and a bile duct
obstruction without cholangitis, according to the timing of ERCP (< 24 h vs. 24–72 h).
Introduction
Acute biliary pancreatitis (ABP), which is the most common form of pancreatitis, develops as
a result of transient obstruction of the bile duct and pancreatic duct, which results in bile reflux
or increased hydrostatic pressure in the pancreatic duct [1]. Endoscopists who perform endo-
scopic retrograde cholangiopancreatography (ERCP) frequently perform urgent ERCP in
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patients with ABP and a concomitant biliary obstruction, in the belief that this procedure
reduces morbidity and mortality.
However, most cases of ABP are self-limiting and improve with conservative treatment; this
is because most gallstones that cause ABP spontaneously pass to the duodenum. Moreover, the
incidence of post-ERCP complications, including pancreatitis, bleeding, cholangitis, bowel
perforation, and cholecystitis is relatively high [2]. Cavdar et al. [3] reported that up to 15% of
stones seen during an acute attack of ABP pass spontaneously after the attack. However, in a
few patients, persistent bile duct stones can lead to ongoing pancreatic duct or bile duct
obstructions, in turn leading to severe acute pancreatitis or cholangitis. Therefore, urgent
ERCP (within 24 h) after admission is recommended in patients with cholangitis, and early
ERCP (within 72 h) after admission is recommended in patients with evidence of a biliary
obstruction without cholangitis [4]. However, there is no definite consensus concerning the
optimal timing of ERCP in such patients.
Despite the many studies on ERCP in patients with ABP, and the availability of clinical
practice guidelines, it remains controversial whether endoscopists should perform ERCP in
patients with ABP and biliary obstruction within 24 h [2,5,6]. We retrospectively reviewed
patients with ABP and a bile duct obstruction without cholangitis to evaluate the optimal tim-
ing for ERCP in these patients.
Materials and methods
Patients
We retrospectively collected clinical data from patients who had been diagnosed with acute
pancreatitis at Severance Hospital, South Korea from January 2005 to December 2014. Among
the patients, we excluded those with the following concomitant conditions or characteristics:
1) cholangitis, which was defined as total bilirubin> 1.2 mg/dL and body temperature> 38.4˚-
C [7], 2) age< 20 or > 90 years, 3) known bleeding disorder or severe coagulopathy that could
not be sufficiently corrected, such as decompensated liver cirrhosis or idiopathic thrombocyto-
penia (platelet count< 50,000 cells/ml), 4) prolonged international normalized ratio of pro-
thrombin time > 1.5, 5) time to ERCP > 72 h after admission, and 6) cholecystectomy during
admission (because simultaneous cholecystectomy prolongs the total length of hospitalization;
S1 Table). ERCP was done during the daytime on weekdays because the endoscopic room was
open and ERCP was readily available. In addition, ERCP was not performed emergently on
weekends if the patient was not indicated for urgent ERCP. Therefore, it was possible to collect
a relatively similar amount of data according to ERCP timing after admission. We divided the
patients with biliary pancreatitis into two groups: those receiving ERCP in< 24 h after admis-
sion (urgent ERCP) and those receiving ERCP 24–72 h after admission (early ERCP). All ini-
tial laboratory analyses were obtained within 24 h of admission, and imaging studies were
performed within the first 48 h of admission. This study was performed in accordance with the
ethical guidelines of the 1975 Declaration of Helsinki, and approved waa granted by the Insti-
tutional Review Board of Severance Hospital (approval number 4-2016-0929). Given its retro-
spective nature, written informed consent was not required by the board to access the clinical
data.
ERCP procedure
The ERCP procedures were performed by six experienced endoscopists who had at least 5
years of experience; each had previously performed > 1,000 ERCP procedures. ERCPs were
performed under conscious sedation with propofol and pethidine, and monitoring was done
by an anesthesiologist or endoscopist. All ERCPs were conducted under fluoroscopic guidance
ERCP in acute biliary pancreatitis
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cholangiopancreatography; ABP, Acute biliary
pancreatitis; CBD, Common bile duct; CT,
Computed tomography.
to diagnose and manage the obstruction using a large (4.2-mm) accessory channel duodeno-
scope (JF-240, TJF 260V; Olympus Optical Co., Ltd., Tokyo, Japan). Cannulation of the com-
mon bile duct (CBD) was attempted with a conventional cannula (Contour ERCP cannula;
Boston Scientific, Natick, MA, USA) with or without a guidewire, or with a pull-type sphinc-
terotome (Clever-cut [Olympus Optical] or Autotome RX 44 [Boston Scientific]). A precut
papillotomy was attempted when conventional cannulation methods failed.
Definition
Acute pancreatitis was defined by fulfilment of at least two of the following three criteria: 1)
pain in the upper abdomen, 2) serum amylase or lipase concentration more than three times
the upper limit of normal, and 3) imaging features of acute pancreatitis on computed tomogra-
phy (CT) or magnetic resonance imaging [8]. Biliary pancreatitis is related to gallstones/sludge
within the gallbladder or bile duct. Biliary pancreatitis was defined by fulfilment at least one of
the following criteria: 1) gallstones or biliary sludge on imaging, 2) dilated CBD on imaging
(defined as> 8 mm in patients aged 75 years and > 10 mm in patients aged> 75 years),
and 3) alanine aminotransferase more than two times the upper limit of normal [9,10]. A bili-
ary obstruction without cholangitis was defined as a biliary obstruction sign, such as a dilated
CBD or jaundice, without any of the symptoms of cholangitis mentioned above. The total
length of the hospital stay was defined as the time between admission to and discharge, and
the duration of hospitalization after ERCP was defined as the time between performing ERCP
and discharge. ERCP-related complications were defined as follows: 1) clinically relevant
bleeding, presence of melena, hematochezia, or hematemesis, in combination with a decrease
in hemoglobin of 1.3 mmol/L or the need for a blood transfusion; 2) duodenal perforation,
diagnosed on plain radiography or CT scan demonstrating free air in the retroperitoneal space
outlining the left kidney and psoas muscle; 3) cardiovascular complications, such as myocar-
dial infarction, cerebrovascular accident, or shock; and 4) post-ERCP pancreatitis diagnosed
according to the signs and symptoms of pancreatitis with elevated pancreatic enzymes after
ERCP [11].
We rated the patient’s pancreatitis severity using the Bedside Index for Severity in Acute
Pancreatitis (BISAP) [12]. The BISAP uses five criteria: blood urea nitrogen > 25 mg/dl,
impaired mental status as evidenced by disorientation or disturbance in mental status, pres-
ence of systemic inflammatory response syndrome (SIRS), age> 60 years, and pleural effu-
sion. SIRS was defined by fulfilment of two or more of the following criteria: pulse > 90 beats/
min, > 20 breaths per min, PaCO2 < 32 mmHg, temperature > 38˚C or < 36˚C, and white
blood cell count > 12,000 or< 4,000 cells per mm3.
Outcomes
In both groups, the primary outcomes were total length of hospitalization and ERCP-related
complications. The secondary outcomes included mortality, technical success rate, and clinical
success rate. Technical success was defined as successful removal of stones or sludge from the
bile duct. Clinical success was defined as normalization of the serum levels of pancreatic
enzymes and relief of symptoms, such as abdominal pain.
Statistical analysis
All data are expressed as medians (± standard deviation) or n (%), as appropriate. The Mann–
Whitney U test was used to compare continuous variables, and the chi-square test or Fisher’s
exact test was used for categorical variables. All statistical analyses were conducted with SPSS
ERCP in acute biliary pancreatitis
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software (ver. 23.0; SPSS Inc., Chicago, IL, USA), and a P-value< 0.05 was considered
significant.
Results
Patient characteristics
A total of 505 patients diagnosed with acute pancreatitis were evaluated. Among the 505
patients, 207 were diagnosed with ABP and a biliary obstruction. A total of 134 patients were
excluded according to the exclusion criteria (89 patients with cholangitis, 9 with time to
ERCP> 72 h after admission, 5 aged< 20 or> 90 years, 3 with coagulation abnormalities,
and 28 with simultaneous cholecystectomy during hospitalization). Thus, 73 patients were
finally enrolled in the present study (Fig 1). The clinical characteristics of the patients are listed
in Table 1. Among the patients, 39 (53.4%) underwent urgent ERCP and 34 (46.6%) under-
went early ERCP. ERCP duration (mean ± SD) was 13 ± 9 h and 48 ± 12 h in the urgent ERCP
and early ERCP groups, respectively. The mean age of the patients was 55.0 and 65.5 years,
and the proportion of male patients was 53.8% and 58.8% in the urgent and early ERCP
Fig 1. Study population enrolled in the present study. Among 505 patients with acute pancreatitis, 207 patients had a diagnosis of acute biliary pancreatitis. According
to the exclusion criteria, a total of 73 patients were enrolled in the present study.
https://doi.org/10.1371/journal.pone.0190835.g001
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groups, respectively. The level of total bilirubin was higher in the urgent ERCP group than in
the elective early ERCP group, and the level of C-reactive protein was higher in the early ERCP
group than in the urgent ERCP group. No differences in any other baseline characteristics
were observed between the groups.
Outcomes
The characteristics of ERCP performed in 73 patients are described in Table 2. The technical
success rate was 97.4% (38/73) in the urgent ERCP group and 94.1% (32/73) in the early elec-
tive ERCP group. However, no difference in technical success rate was detected between the
two groups (P = 0.476). In 45 (61.6%) patients, bile duct stones were detected and the stones
were successfully extracted in 42 (93.3%) of these patients without complications. The reasons
for technical failure of ERCP in both groups were mucosal edema or impacted stones, or ana-
tomical difficulties during cannulation, for example due to a diverticulum.
Table 1. Baseline characteristics.
Variable time to ERCP (n = 73) P-value
 24 h (n = 39) 24–72 h (n = 34)
Male 21 (53.8) 20 (58.8) 0.669
Age, years (range) 55.0 (31–90) 65.5 (26–85) 0.089
Symptom on admission 0.633
Abdominal pain 35 (89.7) 28 (82.4)
Nausea/vomiting 3 (7.7) 4 (11.8)
Jaundice 1 (2.6) 2 (5.8)
Total bilirubin, mg/dL 4.1 ± 4.3 2.3 ± 1.9 0.031
Direct bilirubin, mg/dL 2.9 ± 3.7 2.1 ± 1.4 0.338
ALP, IU/L 167 ± 98 164 ± 135 0.918
r-GT, IU/L 404 ± 337 482 ± 469 0.468
AST, IU/L 218 ± 223 245 ± 235 0.622
ALT, IU/L 288 ± 261 209 ± 166 0.141
Amylase, U/L 1601 ± 1412 1434 ± 1056 0.579
Lipase, U/L 3778 ± 3956 3316 ± 3283 0.596
WBC, /μL 9144 ± 2792 10,318 ± 3768 0.132
CRP, mg/L 6.1 ± 5.9 24.5 ± 30.4 0.011
Diagnosis of biliary pancreatitis 0.124
Elevated total bilirubin 0 (0) 2 (5.9)
CBD stone 16 (41) 18 (52.9)
GB stone 6 (15.4) 1 (2.9)
Bile duct dilatation 0 (0) 1 (2.9)
Combined 17 (43.6) 12 (35.3)
Severity index of pancreatitis† 0.527
<2 29 (74.4) 23 (67.6)
2 10 (25.6) 11 (32.4)
Variables are expressed as mean ± SD or n (%).
ALP, alkaline phosphatase; r-GT, γ-glutamyltransferase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; WBC, white blood cell; CRP, C-reactive
protein; CBD, common bile duct; GB, gallbladder
Some patients had more than one symptoms and signs
†BISAP, bedside index for severity in acute pancrieatitis
https://doi.org/10.1371/journal.pone.0190835.t001
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Table 3 shows the hospitalization duration, ERCP-related complications, pancreatitis-
related complications, and severity of pancreatitis of the patients. Diffuse pancreatic swelling
suggestive of acute pancreatitis was noted on the initial abdominal CT scan in all patients.
However, pancreatic necrosis or pancreatic pseudocysts was not noted on the initial abdomi-
nal CT scan. The urgent ERCP group tended to have a longer duration of hospitalization after
ERCP compared with the elective early ERCP group (5.1 vs. 3.4 days, P = 0.085). The total
length of hospital stay, which may be associated with cost, was not significantly different
between the urgent ERCP group and the elective early ERCP group (5.9 vs. 5.7 days,
P = 0.174).
Seven patients experienced ERCP-related complications. No significant difference was
observed in the complications rate between the two groups (P = 0.113). Two patients in the
urgent ERCP group bled after sphincterotomy. All bleeding events were controlled by a local
injection of epinephrine (dilution, 1:10,000) and closed observation; no blood transfusions
were needed. No other immediate complications, such as perforation of the duodenal wall,
were detected in either group.
We also investigated pancreatitis-related complications, which were defined according to
the Atlanta classification [13]. The only systemic complication was renal failure, seen in three
patients. Renal failure was defined as a serum creatinine level > 2 mg/dl after rehydration or a
need for hemofiltration or hemodialysis. No significant difference was detected between the
Table 2. Characteristics of ERCP procedures performed in patients.
ERCP characteristics Variable time to ERCP (n = 73) P-value
 24 h (n = 39) 24–72 h (n = 34)
Technical success rate 38 (97.4) 32 (94.1) 0.476
Sludge in CBD 7 (17.9) 4 (11.8) 0.461
Stones in CBD 23 (59.0) 22 (64.7) 0.615
Variables are expressed as the n (%).
ERCP, endoscopic retrograde cholangiopancreatography; CBD, common bile duct; P-duct, pancreatic duct.
https://doi.org/10.1371/journal.pone.0190835.t002
Table 3. Hospitalization day and complications.
Variable time to ERCP P-value
 24 h (n = 39) 24–72 h (n = 34)
Total length of hospital stay, days 5.9 ± 5.0 5.7 ± 2.5 0.174
Duration of hospitalization after ERCP, days 5.1 ± 5.0 3.4 ± 2.6 0.085
Post-ERCP complications 0.113
Sepsis 1 (2.6) 0 (0)
Cholangitis 3 (7.7) 1 (2.9)
Bleeding 2 (5.1) 0 (0)
Perforation 0 (0) 0 (0)
Complications due to pancreatitis† 1 (2.6) 2 (5.8) 0.476
Severity of pancreatitis†† 0.9 ± 0.9 1.1 ± 0.9 0.670
Variables are expressed as the mean ± SD or n (%).
The total length of hospital stay is the duration from admission to discharge.
The duration of hospitalization after ERCP is the duration from ERCP to discharge.
†All pancreatitis-related complications are renal failure
††BISAP, bedside index for severity in acute pancreatitis
https://doi.org/10.1371/journal.pone.0190835.t003
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urgent ERCP group (< 24 h) and early ERCP group (24–72 h) regarding the frequency of pan-
creatitis-related complications (2.6% vs. 5.8%, P = 0.476) (Table 3).
We chose the BISAP severity scoring system to measure pancreatitis severity. The propor-
tions of patients according to BISAP scores were as follows: 0 (n = 27, 37%), 1 (n = 25, 34.2%),
2 (n = 16, 21.9%), and 3 (n = 5, 6.8%) (Table 4). No significant difference in median pancre-
atitis severity score was observed between the groups (P = 0.670) (Table 3).
Discussion
In the present study, we investigated the need for urgent ERCP within 24 h to control biliary
obstructions in patients with ABP. Based on the results of this study, urgent ERCP is not supe-
rior to elective early ERCP in terms of complications or hospitalization duration. Furthermore,
there were no differences in the technical or clinical success rates between the two groups.
Several clinical trials have aimed to identify the proper timing of ERCP for patients with
ABP, to reduce the rate of mortality and complications. Neoptolemos et al. [14] showed that
patients with predicted severe acute pancreatitis had fewer complications if they underwent
early ERCP (within 72 h of admission; 24% vs. 61%, P< 0.05). On the other hand, Folsch et al.
[15] reported that early ERCP was not beneficial in patients with ABP but without obstructive
jaundice and cholangitis. A recently published meta-analysis showed no significant difference
in mortality rate according to the timing of ERCP (< 24 h vs. < 72 h) [6].
However, the timing of the procedure was defined differently in previous studies including
patients with ABP, such as< 24 h after admission [16,17], < 72 h after admission [7,14,18],
and< 72 h after symptom onset [15]. In the present study, the patients were divided into two
groups according to the time of intervention after admission, which has more practical appli-
cability to daily practice. In previous studies, the diagnostic criteria for gallstone pancreatitis
and cholangitis also varied [2,5,19]. One reasons for this is that it is occasionally difficult to
diagnose patients with CBD stones or gallstone pancreatitis. Moreover, commonly used bio-
chemical and radiological predictors of biliary obstruction are unreliable during the early
phase of ABP. The liver function test is normal in about 15–20% of patients with ABP,
although it can be commonly checked, and abdominal ultrasonography has a low sensitivity
(27–50%) for CBD stones or dilatation [9,20]. In the present study, the diagnosis of biliary pan-
creatitis was based on imaging and laboratory results according to international consensus
guidelines [2,5].
Previous animal and human studies have suggested that the severity of pancreatitis is
related to the duration of a bile duct obstruction, which is therefore a critical factor contribut-
ing to the severity of pancreatitis [21,22]. Thus, early ERCP within 72 h may be helpful for
decompressing the biliary obstruction, although our study demonstrated that urgent biliary
intervention within 24 h would not lead to the additive benefit of reduced total hospital stay
Table 4. Number of patients stratified by the BISAP point score.
BISAP score† Variable time to ERCP Total
 24 h (n = 39) 24–72 h (n = 34)
0 18 (46.2) 9 (26.5) 27 (37.0)
1 11 (28.2) 14 (41.2) 25 (34.2)
2 8 (20.5) 8 (23.5) 16 (21.9)
3 2 (5.1) 3 (8.8) 5 (6.8)
Variables are expressed as n (%)
†BISAP, bedside index for severity in acute pancreatitis
https://doi.org/10.1371/journal.pone.0190835.t004
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and complication rates. In particular, the cost-effectiveness of urgent ERCP should also be
considered [23].
In previous studies, the cut-off level of total bilirubin for defining cholestasis varied and
patients with total bilirubin levels of 1.2–5.0 mg/dL were included in the cholestatic group
[6,24,25]. In this study, the level of total bilirubin was higher in the urgent ERCP group than in
the elective early ERCP group, which might have affected the timing of ERCP in patients with
cholestasis. We performed a subgroup analysis to exclude the effect of total bilirubin on total
length of hospital stay and complications. The subgroup analysis after matching the level of
total bilirubin still did not show a significant difference in total length of hospital stay or com-
plications between the groups (S2 Table).
We performed pre-specified subgroup analyses according to the predicted severity of pancre-
atitis. No significant differences were detected in the risk of complications or total length of hos-
pital stay between two groups, regardless of predicted severity (Table 5). In recent clinical trials
and guidelines, ERCP is not recommended in most patients with ABP for whom there is a lack
of evidence of biliary obstruction or cholangitis, regardless of predicted severity [2,4,5]. In this
study, we found no clinical difference between the two groups (<24 h vs. 24–72 h) in terms of
ERCP-related complications or total length of hospital stay, regardless of predicted severity.
This study had several limitations. First, it used a nonrandomized, retrospective design.
The optimal study design is a prospective, randomized control trial, not an observational
study. However, we tried to exclude confounders related to ERCP timing, such as cholangitis,
operation, and age, to reduce selection bias. Second, the present study had a small sample size.
Table 3 shows that there were complication rates of and 1/34 in the urgent and early ERCP
group, respectively. The number of patients with complications was lower in the early ERCP
group than in the urgent ERCP group. Even if the proportion of complications in the two
groups did not differ significantly, there was a possibility of a type II error considering the
small sample size. Because of the small number of patients per group, the study was underpow-
ered to detect meaningful differences. It might indeed be that early ERCP is associated with a
lower complication rate compared to urgent ERCP.
This is the first study to evaluate the optimal timing of ERCP for patients with ABP and a
biliary obstruction without cholangitis. We found no clinical difference between the two
Table 5. Hospitalization day and complications stratified by BISAP score†.
Variable time to ERCP P-value
 24 h (n = 39) 24–72 h (n = 34)
BISAP < 2 Total length of hospital stay, days 4.5 ± 2.3 5.6 ± 1.8 0.065
Duration of hospitalization after ERCP, days 3.6 ± 2.3 2.9 ± 1.7 0.228
Post-ERCP complications 4/29 0/23 0.063
Complications due to pancreatitis 0/29 0/23 NA
BISAP 2 Total length of hospital stay, days 10.1 ± 7.6 6.5 ± 3.4 0.184
Duration of hospitalization after ERCP, days 9.3 ± 7.5 4.3 ± 3.6 0.071
Post-ERCP complications 2/10 1/11 0.475
Complications due to pancreatitis 1/10 2/11 0.592
Variables are expressed as the mean ± SD or n (%).
The total length of hospital stay is the duration from admission to discharge.
The duration of hospitalization after ERCP is the duration from ERCP to discharge.
†BISAP, bedside index for severity in acute pancreatitis.
NA, not applicable.
https://doi.org/10.1371/journal.pone.0190835.t005
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groups (< 24 h vs. 24–72 h) in terms of ERCP-related complications or total hospitalization
duration. In conclusion, urgent ERCP is not superior to early ERCP in patients with biliary
pancreatitis without cholangitis.
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